0.76 | 0.89%
- Employers: Entry-Level Applicants Are Just About Useless
- Walmart vs. Costco: How Do They Really Compare?
- Tesla Pops on GM Rumor (Update 1)
- Putting a Fingerprint on Every Bullet
- Why Apple Sucks as an Investment, but Amazon Doesn't
|
|
|
|
|
Valeant Pharmaceuticals International Inc (VRX)
NYSE: Health Care
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 916.09M | 164.11M | 394.27M | 114.46M |
| Receivables | 913.84M | 577.50M | 283.06M | 119.92M |
| Inventories | 531.26M | 355.21M | 229.58M | 82.77M |
| Other Current Assets | 90.98M | 72.24M | 4.01M | 8.54M |
| Total Current Assets | 2.78B | 1.36B | 1.02B | 350.64M |
| Property, Plant & Equipment, Gross | 636.23M | 540.03M | 404.46M | 221.95M |
| Accumulated Depreciation & Depletion | 173.51M | 125.79M | 122.71M | 118.10M |
| Property, Plant & Equipment, Net | 462.72M | 414.24M | 281.75M | 103.85M |
| Intangibles | 9.31B | 7.66B | 6.37B | 1.34B |
| Other Non-Current Assets | 183.75M | 58.70M | 38.96M | 44.24M |
| Total Non-Current Assets | 15.17B | 11.78B | 9.77B | 1.72B |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 17.95B | 13.14B | 10.80B | 2.07B |
| Accounts Payable | 227.38M | 157.62M | 101.32M | 72.02M |
| Short Term Debt | 480.18M | 111.25M | 116.90M | 12.11M |
| Other Current Liabilities | 19.91M | 110.60M | 9.80M | 42.93M |
| Total Current Liabilities | 1.82B | 924.27M | 692.46M | 256.91M |
| Long Term Debt | 10.54B | 6.54B | 3.57B | 380.18M |
| Deferred Income Taxes | 1.35B | 1.24B | 1.44B | 0.00 |
| Other Non-Current Liabilities | 522.82M | 434.65M | 180.34M | 75.59M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 12.41B | 8.21B | 5.19B | 455.77M |
| Total Liabilities | 14.23B | 9.13B | 5.88B | 712.67M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 3.72B | 4.01B | 4.91B | 1.35B |
| Common Par | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Paid In Capital | 6.21B | 6.24B | 5.75B | 1.56B |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -2.37B | -2.03B | -934.51M | -245.97M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -119.40M | -202.43M | 98.84M | 43.57M |
| Total Capitalization | 14.25B | 10.55B | 8.49B | 1.73B |
| Total Equity | 3.72B | 4.01B | 4.91B | 1.35B |
| Total Liabilities & Stock Equity | 17.95B | 13.14B | 10.80B | 2.07B |
| Total Common Shares Outstanding | 303.86M | 306.37M | 302.45M | 158.31M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 305.45M | 304.66M | 195.81M | 158.24M |
| Diluted Weighted Shares Outstanding | 305.45M | 326.12M | 195.81M | 158.51M |
| Number of Employees | 7000 | 6900 | 4300 | 1291 |
| Number of Part-Time Employees | 0 | 0 | 0 | 20 |
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
|
|
Brokerage Partners
|
|
|
|
|
|
|
|
Most Commented
Advertising Partners
|
|
|
|
We respect your privacy.